Antibe Therapeutics Inc(Pre-Merger) ATBPF

RE:RE:RE:RE:RE:RE:RE:RE:RE:52 week low

[JimmyJ]

MrMugsy wrote:

JimmyJ wrote:

Doccole wrote:

I don't mind him as a person, prolly a great guy.  I don't like how this strategy has unfolded.  I am not sure what is up for vote, haven't looked yet, but I will be saying no to any "atta boy" shares and no to things I don't endorse. 

 

Where do you think the SP would today if the Connacord raise didn't happen back February following the Nuance deal?

 

We'll never know but based on historical data in this industry, it would gone up maybe to $8 or $10 max, followed by a slow bleed back to these levels guaranteed.  When catalysts are 6-8 months apart, these stocks always drop.  It's the nature of biotech.   It's a damned if you do, more damned if you don't situation for Dan.  He had an opportunity to increase the cash reserve with little impact knowing exactly where the SP was going in the long run this year. It was the right call IMO.  

As sad as it is, this won't be the last time we see a major claw back with this stock.  There will likely be many more before they hit it out of the park.   It's going to be a bumpy ride to get there.   Sit back, buckle up and enjoy.

 

 

Well said Jimmy.
Ya - lots of up and down stock price play for those that remain shareholders ... I'm sure.
Hopefully hitting higher highs and higher lows along the way forward.

 

Agreed. Higher low's will come after meeting significant milestone and higher "sustainable" high's will come when real dollars come through the door; either from licensing, a buyout or manufacturing.

There is a laundry list of good things done recently that has set the stage for hopefully even better things to come.

As much as people don't like it or Dan, I don't see it making a big difference in a vote.  The board and the big players are looking towards the future with this play and it's looking like it's tee'd up nicely for success.  Time will tell.